Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Meeting on the Med 2021 and Regulation
View overview page
1:46
Regulating gene therapies: what can be learned from COVID-19?
Nicole Faust
• 9 Apr 2021
3:35
Tackling manufacturing challenges in advanced therapies
Matthew Durdy
• 9 Apr 2021
3:42
Challenges with ATMP clinical trials in Europe
Ana Hidalgo-Simon
• 7 Apr 2021
5:14
Improving patient access to advanced therapies
Ana Hidalgo-Simon
• 7 Apr 2021
4:17
Driving the ATMP sector forward: a regulatory perspective
Ana Hidalgo-Simon
• 7 Apr 2021
1:27
The European cell & gene therapy landscape
Paige Bischoff
• 17 Mar 2021
2:05
The challenges of CMC in cell and gene therapies
Mike Lehmicke
• 17 Mar 2021
2:21
Supporting the future of ATMPs in the EU
Paige Bischoff
• 17 Mar 2021
3:08
Accelerating commercialization in advanced therapies
Pascal Touchon
• 7 Apr 2021
